Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Clinical Trials > Metabolomic and Inflammatory Profiling in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Jumbo Large Regular Text:
Print
Clinical Trials

Metabolomic and Inflammatory Profiling in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Related Content

Health Articles

  • Understanding Clinical Trials: A participants' guide

In This Section

Related Clinical Trials

  • Pulmonology and Respiratory Medicine

Share

The purpose of this study is to look at how cells outside the lungs behave in patients with COPD (chronic bronchitis or emphysema) compared with healthy people, to determine what specific products these cells produce, and how they are affected by treatment.

Eligibility Requirements

To qualify, participants must be:

  • An adult, 40 to 80 years old, with COPD (chronic bronchitis or emphysema)
  • A current or former smoker with more than 20 pack years
    • One pack year is defined as 20 manufactured cigarettes (one pack) smoked per day for one year.
  • Able to walk on treadmill

Study Requirements

The study will last for approximately 12 weeks and will involve three visits to the clinic.

Compensation

You will be compensated a total of $200 for your expenses related to your participation.

For more information, contact Denise Beaver or Mikki Aragaw at 919-479-0719 or beave006@mc.duke.edu.


(REF# 3560)
Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Oct. 4, 2011
Published: Oct. 4, 2011
URL: http://www.dukehealth.org/clinicaltrials/metabolic-inflammatory-profiling-in-patients-with-copd